LIVIVO - Search results -

Search results

Result 1 - 10 of total 78

Search options

Article ; Online: Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications.

Abebe, Endeshaw Chekol / Dejenie, Tadesse Asmamaw

2023 Volume 14, Page(s) 1055457

Abstract: Neutralizing antibodies (NAbs) are central players in the humoral immunity that defends the body from SARS-CoV-2 infection by blocking viral entry into host cells and neutralizing their biological effects. Even though NAbs primarily work by neutralizing ... ...

Abstract	Neutralizing antibodies (NAbs) are central players in the humoral immunity that defends the body from SARS-CoV-2 infection by blocking viral entry into host cells and neutralizing their biological effects. Even though NAbs primarily work by neutralizing viral antigens, on some occasions, they may also combat the SARS-CoV-2 virus escaping neutralization by employing several effector mechanisms in collaboration with immune cells like natural killer (NK) cells and phagocytes. Besides their prophylactic and therapeutic roles, antibodies can be used for COVID-19 diagnosis, severity evaluation, and prognosis assessment in clinical practice. Furthermore, the measurement of NAbs could have key implications in determining individual or herd immunity against SARS-CoV-2, vaccine effectiveness, and duration of the humoral protective response, as well as aiding in the selection of suitable individuals who can donate convalescent plasma to treat infected people. Despite all these clinical applications of NAbs, using them in clinical settings can present some challenges. This review discusses the protective functions, possible protective mechanisms against SARS-CoV-2, and potential clinical applications of NAbs in COVID-19. This article also highlights the possible challenges and solutions associated with COVID-19 antibody-based prophylaxis, therapy, and vaccination.
MeSH term(s)	Humans ; Antibodies, Neutralizing ; COVID-19 ; SARS-CoV-2 ; COVID-19 Testing ; COVID-19 Serotherapy ; Antibodies, Viral
Chemical Substances	Antibodies, Neutralizing ; Antibodies, Viral
Language	English
Publishing date	2023-01-19
Publishing country	Switzerland
Document type	Journal Article ; Review
ZDB-ID	2606827-8
ISSN	1664-3224 ; 1664-3224
ISSN (online)	1664-3224
ISSN	1664-3224
DOI	10.3389/fimmu.2023.1055457
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Article ; Online: Human immunodeficiency virus positive status disclosure among children in northwest Ethiopia: a cross-sectional study.

Adella, Getachew Asmare / Yimer, Meklit Abie / Abebe, Endeshaw Chekol

African health sciences

2023 Volume 23, Issue 1, Page(s) 178–189

Abstract: Background: Human Immunodeficiency Virus positive status disclosure is an essential component of pediatric care and longterm disease management. However, one of the greatest challenges that caregiver/mothers and health care workers face is the ... ...

Abstract	Background: Human Immunodeficiency Virus positive status disclosure is an essential component of pediatric care and longterm disease management. However, one of the greatest challenges that caregiver/mothers and health care workers face is the disclosure of HIV positive status to children living with the virus. Therefore, the objective of this study was to assess HIV positive status disclosure and associated factors among HIV positive children in northwest Ethiopia. Methods: Institutional based cross-sectional study was conducted among 417 sampled HIV positive children attending pediatric ART clinics of public health facilities from February 01 to March 30 2020 in northwest Ethiopia. Simple random sampling technique was used to select study participants. A structured interviewer administered questionnaire was used for data collection and the collected data entered into Epi data software. Binary logistic regression analysis was done and variables with P-value <0.05 was considered as a significant predictors of HIV positive status disclosure of HIV positive children. Result: From 417 sampled population, 390 were involved in this study making 93.5% response rate. The study revealed that 53.6% with 95% CI (0.486-0.586) of HIV positive children knew their HIV positive sero status. Caregiver/mothers who had greater than three family sizes (AOR=1.984, 95% CI=1.046-3.762), children whose ages greater than 10 years (AOR=6.679, 95% CI=3.372-13.227) and children on ART for more than 5 years (AOR=8.96, 95% CI=6.402-12.257) were predictors of HIV positive status disclosure. Conclusion: The HIV positive status disclosure was high in the study area relative to other studies. Family size, children age, and length of children on ART were predictors of HIV positive status disclosure for HIV positive children. Health care providers, especially those working at pediatrics ART clinics should keep these factors in mid while working with caregivers to encourage disclosure of HIV positive status.
MeSH term(s)	Female ; Humans ; Child ; Disclosure ; HIV Infections/epidemiology ; Cross-Sectional Studies ; Ethiopia/epidemiology ; HIV Seropositivity ; Ambulatory Care Facilities ; Surveys and Questionnaires ; HIV
Language	English
Publishing date	2023-07-21
Publishing country	Uganda
Document type	Journal Article
ZDB-ID	2240308-5
ISSN	1729-0503 ; 1680-6905
ISSN (online)	1729-0503
ISSN	1680-6905
DOI	10.4314/ahs.v23i1.20
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 3851: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Frequency and correlates of poor glycemic control in patients with type 2 diabetes at Jimma Medical Centre, Ethiopia: a cross-sectional study.

Mengstie, Misganaw Asmamaw / Abebe, Endeshaw Chekol / Dejenie, Tadesse Asmamaw / Seid, Mohammed Abdu / Teshome, Assefa Agegnehu

The Pan African medical journal

2024 Volume 47, Page(s) 7

Abstract: Introduction: the majority of studies in Ethiopia determine the prevalence of glycemic control employed by fasting blood sugar (FBS), which is impacted by a variety of factors. Hence, the purpose of this study was to assess the status of glycemic ... ...

Abstract	Introduction: the majority of studies in Ethiopia determine the prevalence of glycemic control employed by fasting blood sugar (FBS), which is impacted by a variety of factors. Hence, the purpose of this study was to assess the status of glycemic control using HbA1c and its correlates in patients with type 2 diabetes in Southwest Ethiopia. Methods: a cross-sectional study was employed among 124 T2 diabetes mellitus (DM) patients at Jimma Medical Center (JMC), Southwest Ethiopia. HbA1c and FBS were estimated using the Cobas 6000 analyzer. The body mass index (BMI) and waist-to-hip ratio were calculated as the standard formula. Data were analyzed by SPSS version 25. Logistic regression analysis was employed to identify independent risk factors associated with poor glycemic control of DM patients. Results: males comprised 63.7% (n=79) of the total respondents. The mean age of aOR: 2.21, 95% CI 1.13, 4.34; p = 0.01f participants was 51.84 ± 11.6 years; 60.5% (n=75) of T2 DM patients were in poor glycemic control (HbA1c ≥ 7%). In multivariate logistic regression analysis, BMI of ≥ 30, (aOR: 2.21, 95% CI 1.13, 4.34) increased waist-to-hip ratio (aOR: 1.63, 95% CI 0.82, 2.18), high systolic blood pressure (aOR: 1.52, 95% CI 1.11, 6.23), high FBS (aOR: 1.61, 95% CI 1.00, 4.12), and longer duration of DM (aOR: 1.23, 95% CI 0.87, 1.88) were associated with poor glycemic control. Conclusion: the level of poor glycemic control in the study population is high. Obesity and/or overweight, central obesity, systolic hypertension, and fasting blood sugar levels were all associated with poor glycemic control in T2 DM patients.
MeSH term(s)	Male ; Humans ; Female ; Diabetes Mellitus, Type 2/complications ; Cross-Sectional Studies ; Blood Glucose ; Ethiopia/epidemiology ; Glycated Hemoglobin ; Glycemic Control ; Hyperglycemia/epidemiology ; Obesity/complications
Chemical Substances	Blood Glucose ; Glycated Hemoglobin
Language	English
Publishing date	2024-01-08
Publishing country	Uganda
Document type	Journal Article
ZDB-ID	2514347-5
ISSN	1937-8688 ; 1937-8688
ISSN (online)	1937-8688
ISSN	1937-8688
DOI	10.11604/pamj.2024.47.7.37452
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: Phytochemical Investigation and Determination of Antibacterial Activity of Solvent Leave Extracts of

Ayalew Tiruneh, Tizezew / Ayalew Tiruneh, Gebrehiwot / Chekol Abebe, Endeshaw / Mengie Ayele, Teklie

Infection and drug resistance

2022 Volume 15, Page(s) 807–819

Abstract: Background: Among many traditionally used medicinal plants, : Methods: In this study, 800 g of powdered leaves of : Results: The three extracts (methanol, ethyl acetate, and chloroform) of : Conclusion: Data obtained from this study ... ...

Abstract	Background: Among many traditionally used medicinal plants, Methods: In this study, 800 g of powdered leaves of Results: The three extracts (methanol, ethyl acetate, and chloroform) of Conclusion: Data obtained from this study collectively indicated that the three solvent extracts of
Language	English
Publishing date	2022-03-04
Publishing country	New Zealand
Document type	Journal Article
ZDB-ID	2494856-1
ISSN	1178-6973
ISSN	1178-6973
DOI	10.2147/IDR.S352049
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: Investigation of Antibacterial and Anti-Diarrhoeal Activities of 80% Methanol Leaf and Fruit Extract of

Mengie Ayele, Teklie / Chekol Abebe, Endeshaw / Bogale Kassie, Achenef

publication RETRACTED

Journal of experimental pharmacology

2021 Volume 13, Page(s) 613–626

Abstract: Background: Leonotis ocymifolia: Methods: The leaves and fruits of : Results: A significant (: Conclusion: Results from this study collectively indicated that 80% methanol leaf and fruit extracts ... ...

Abstract	Background: Leonotis ocymifolia Methods: The leaves and fruits of Results: A significant ( Conclusion: Results from this study collectively indicated that 80% methanol leaf and fruit extracts of
Language	English
Publishing date	2021-06-29
Publishing country	New Zealand
Document type	Journal Article ; Retracted Publication
ZDB-ID	2587465-2
ISSN	1179-1454
ISSN	1179-1454
DOI	10.2147/JEP.S319981
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: Regulatory effects and potential therapeutic implications of alarin in depression, and arguments on its receptor.

Abebe, Endeshaw Chekol / Mengstie, Misganaw Asmamaw / Seid, Mohammed Abdu / Dejenie, Tadesse Asmamaw

Frontiers in psychiatry

2022 Volume 13, Page(s) 1051235

Abstract: Alarin is a pleiotropic peptide involved in a multitude of putative biological activities, notably, it has a regulatory effect on depression-like behaviors. Although further elucidating research is needed, animal-based cumulative evidence has shown the ... ...

Abstract	Alarin is a pleiotropic peptide involved in a multitude of putative biological activities, notably, it has a regulatory effect on depression-like behaviors. Although further elucidating research is needed, animal-based cumulative evidence has shown the antidepressant-like effects of alarin. In light of its regulatory role in depression, alarin could be used as a promising antidepressant in future treatment for depression. Nevertheless, the available information is still insufficient and the therapeutic relevance of alarin in depression is still of concern. Moreover, a plethora of studies have reported that the actions of alarin, including antidepressant activities, are mediated by a separate yet unidentified receptor, highlighting the need for more extensive research. This review focuses on the current understanding of the regulatory effects and future therapeutic relevance of alarin on depression, and the arguments on its receptors.
Language	English
Publishing date	2022-11-25
Publishing country	Switzerland
Document type	Journal Article ; Review
ZDB-ID	2564218-2
ISSN	1664-0640
ISSN	1664-0640
DOI	10.3389/fpsyt.2022.1051235
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Incidence and predictors of early posttraumatic seizures among patients with moderate or severe traumatic brain injury in Northwest Ethiopia: an institution-based prospective study.

Baye, Nega Dagnew / Baye, Fikadie Dagnew / Teshome, Assefa Agegnehu / Ayenew, Atalo Agimas / Mulu, Anmut Tilahun / Abebe, Endeshaw Chekol / Muche, Zelalem Tilahun

BMC neurology

2024 Volume 24, Issue 1, Page(s) 41

Abstract: Background: Early posttraumatic seizure (PTS) is a well-known complication of traumatic brain injury (TBI) that can induce the development of secondary brain injuries, including increased intracranial pressure, brain death, and metabolic crisis which ... ...

Abstract	Background: Early posttraumatic seizure (PTS) is a well-known complication of traumatic brain injury (TBI) that can induce the development of secondary brain injuries, including increased intracranial pressure, brain death, and metabolic crisis which may result in worse outcomes. It is also a well-recognized risk factor for the development of late post-traumatic seizure and epilepsy. This study was aimed to assess the incidence and predictors of PTS among patients with moderate or severe TBI admitted to Debre Tabor Comprehensive Specialized Hospital, Northwest Ethiopia. Methods and setting: An institutional-based prospective follow-up study was conducted on 402 patients with TBI admitted to the neurologic unit from June 1, 2022 to January 30, 2023. A systematic sampling technique was employed. The incidence rate of occurrence of early PTS was calculated. Both bivariable and multivariable Cox proportional hazard regression was performed. The strength of the association was measured using adjusted hazard ratios with a 95% confidence interval and p-values < 0.05. Results: The incidence rate of early PTS was 2.7 per 100 person-days observation. Early PTS was observed in 17.7% of TBI patients. Age 75 and above (AHR = 2.85, 95%CI: 1.58-5.39), severe TBI (AHR = 2.06, 95%CI: 1.03-3.71), epidural hematoma (AHR = 2.4, 95% CI: 1.28-4.57), brain contusion (AHR = 2.6, 95%CI: 1.07-4.09), surgical intervention (AHR = 1.7, 95%CI: 1.03-3.82), posttraumatic amnesia (AHR = 1.99, 95%CI: 1.08-3.48), history of comorbidities (AHR = 1.56, 95%CI: 1.08-3.86), and history of alcohol abuse (AHR = 3.1, 95%CI: 1.89-5.23) were potential predictors of early PTS. Conclusion: The incidence of early PTS was high. Since, early PTS can worsen secondary brain damage, knowing the predictors helps to provide an effective management plan for patients likely to develop early PTS and improve their outcome.
MeSH term(s)	Humans ; Aged ; Prospective Studies ; Incidence ; Ethiopia/epidemiology ; Follow-Up Studies ; Brain Injuries, Traumatic/complications ; Brain Injuries, Traumatic/epidemiology ; Brain Injuries ; Brain Neoplasms ; Seizures
Language	English
Publishing date	2024-01-24
Publishing country	England
Document type	Journal Article
ZDB-ID	2041347-6
ISSN	1471-2377 ; 1471-2377
ISSN (online)	1471-2377
ISSN	1471-2377
DOI	10.1186/s12883-024-03536-z
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Ciltacabtagene autoleucel: The second anti-BCMA CAR T-cell therapeutic armamentarium of relapsed or refractory multiple myeloma.

Chekol Abebe, Endeshaw / Yibeltal Shiferaw, Mestet / Tadele Admasu, Fitalew / Asmamaw Dejenie, Tadesse

Frontiers in immunology

2022 Volume 13, Page(s) 991092

Abstract: Ciltacabtagene autoleucel (also known as cilta-cel) is a chimeric antigen receptor (CAR) T-cell therapy that targets B-cell maturation antigen (BCMA) on the surface of cancer cells in B cell malignancies, such as multiple myeloma (MM). It is a second- ... ...

Abstract	Ciltacabtagene autoleucel (also known as cilta-cel) is a chimeric antigen receptor (CAR) T-cell therapy that targets B-cell maturation antigen (BCMA) on the surface of cancer cells in B cell malignancies, such as multiple myeloma (MM). It is a second-generation CAR that is outfitted with an ectodomain comprising two BCMA-binding single chain variable fragment (ScFv) domains, a transmembrane domain, and an endodomain possessing CD3ζ and 4-1BB. Cilta-cel is an autologous, gene-edited CAR T-cell that is prepared by collecting and modifying the recipient's T-cells to create a patient personalized treatment in the laboratory to be infused back. This CAR T-cell product exceptionally entails CARs with two BCMA-targeting single-domain antibodies that detect two epitopes of BCMA expressed on the malignant cells of MM. Cilta-cel is the current addition to the treatment armamentarium of relapsed or refractory (r/r) MM after its approval by the FDA on February 28, 2022, based on the results of the Phase 1b/2 CARTITUDE-1 study. It was the second approved anti-BCMA CAR T-cell product after idecabtagene vicleucel (ide-cel) to treat myeloma patients. It induces early, deep, and long-lasting responses with a tolerable safety profile in r/r MM. Cilta-cel-treated myeloma patients may potentially experience adverse effects ranging from mild to life-threatening, but they are mostly manageable toxicities. Besides, it has a consistent safety profile upon a longer follow-up of patients. Cilta-cel generally outperforms ide cel in terms of efficacy in MM, but shows comparable adverse events. This review highlights the current updates on cilta-cel efficacy, adverse events, comparison with ide-cel, and its future direction in the treatment of MM.
MeSH term(s)	B-Cell Maturation Antigen ; Clinical Trials, Phase I as Topic ; Clinical Trials, Phase II as Topic ; Epitopes/metabolism ; Humans ; Multiple Myeloma ; Receptors, Chimeric Antigen ; Single-Chain Antibodies/genetics ; Single-Chain Antibodies/metabolism ; Single-Domain Antibodies/metabolism ; T-Lymphocytes
Chemical Substances	B-Cell Maturation Antigen ; Epitopes ; Receptors, Chimeric Antigen ; Single-Chain Antibodies ; Single-Domain Antibodies ; idecabtagene vicleucel (8PX1X7UG4D)
Language	English
Publishing date	2022-09-02
Publishing country	Switzerland
Document type	Journal Article ; Review
ZDB-ID	2606827-8
ISSN	1664-3224 ; 1664-3224
ISSN (online)	1664-3224
ISSN	1664-3224
DOI	10.3389/fimmu.2022.991092
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: Undernutrition and associated factors among internally displaced lactating mothers in Sekota camps, northern Ethiopia: A cross-sectional study.

Mengstie, Misganaw Asmamaw / Worke, Mulugeta Dile / Belay, Yalemshet / Chekol Abebe, Endeshaw / Asmamaw Dejenie, Tadesse / Abdu Seid, Mohammed / Azezew, Muluken Teshome

Frontiers in nutrition

2023 Volume 10, Page(s) 1108233

Abstract: Background: Undernutrition is the term used to describe when a person consumes insufficient amounts of nutrients and energy to meet their needs for maintaining health. Despite substantial progress, undernutrition remains a serious public health concern ... ...

Abstract	Background: Undernutrition is the term used to describe when a person consumes insufficient amounts of nutrients and energy to meet their needs for maintaining health. Despite substantial progress, undernutrition remains a serious public health concern in many low and middle-income nations, including Ethiopia. Women and children are, in reality, the most nutritionally vulnerable individuals, particularly in times of crisis. In Ethiopia, 27 percent of lactating women are thin or malnourished, and 38% of children are stunted. Although the issue of undernutrition may worsen in times of emergency, like war, there are limited studies available in Ethiopia that show the nutritional status of lactating mothers in humanitarian settings. Objectives: The main aim of this study was to determine the prevalence and investigate the factors associated with undernutrition among internally displaced lactating mothers in Sekota camps, in northern Ethiopia. Methods: A cross-sectional study through a simple random sampling technique was conducted among 420 randomly selected lactating mothers in Sekota Internally Displaced Persons (IDP) camps. Data were collected using a structured questionnaire and anthropometric measurements. Logistic regression analysis was employed to identify independent factors associated with maternal undernutrition. Results: Using a cut-off mid-upper arm circumference <23 cm, the prevalence of undernutrition among internally displaced lactating mothers was 54.8%. Large family size [adjusted odds ratio (AOR) = 4.35; 95% CI: 1.32, 10.22], short birth interval (AOR = 4.85; 95% CI: 1.24, 10.00), low maternal daily meal frequency (AOR = 2.54; 95% CI: 1.12, 5.75), and low dietary diversity score (AOR = 1.79; 95% CI: 1.03, 3.10) were all significantly associated with undernutrition. Conclusion: The prevalence of undernutrition among internally displaced lactating mothers is relatively high. Governments and other concerned organizations involved in providing care and support to Sekota IDP camps should increase their efforts to improve the nutritional status of lactating mothers.
Language	English
Publishing date	2023-02-14
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2776676-7
ISSN	2296-861X
ISSN	2296-861X
DOI	10.3389/fnut.2023.1108233
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Blood glucose level and serum lipid profiles among people living with HIV on dolutegravir-based versus efavirenz-based cART; a comparative cross-sectional study.

Jemal, Mohammed / Shibabaw Molla, Tewodros / Tiruneh G Medhin, Markeshaw / Chekol Abebe, Endeshaw / Asmamaw Dejenie, Tadesse

Annals of medicine

2023 Volume 55, Issue 2, Page(s) 2295435

Abstract: Background: Antiretroviral therapy-linked metabolic abnormalities have become a growing concern among people living with HIV. There is limited data regarding the effects of dolutegravir-based treatment on blood glucose levels and serum lipid profiles in ...

Abstract	Background: Antiretroviral therapy-linked metabolic abnormalities have become a growing concern among people living with HIV. There is limited data regarding the effects of dolutegravir-based treatment on blood glucose levels and serum lipid profiles in people living with HIV in Ethiopia. Thus, this study aimed to assess blood glucose levels and serum lipid profiles among people living with HIV on dolutegravir-based versus efavirenz-based therapy. Method and materials: An institutional-based comparative cross-sectional study was conducted from 30 June 2021 to 30 August 2021. A total of 128 participants (64 in the dolutegravir-based group and 64 in the efavirenz-based group) were enrolled in the study. The Chi-square, independent Result: The prevalence of hyperglycemia and dyslipidemia were 17.2% (11/64) and 79.7% (51/64) in the dolutegravir group, and 9.4% (6/64) and 75% (48/64) in the efavirenz group, respectively. The efavirenz group had significantly higher mean values of total cholesterol (190.73 ± 44.13 vs. 175.27 ± 37.67 mg/dl, Conclusion: Efavirenz-based therapy resulted in higher mean values of total cholesterol and high-density lipoprotein as compared with dolutegravir-based therapy. It is important to consider and evaluate high-density lipoprotein levels in HIV patients on dolutegravir-based therapy, and total cholesterol levels in people living with HIV on efavirenz-based therapy.
MeSH term(s)	Humans ; Male ; Female ; HIV Infections/drug therapy ; Blood Glucose ; Cross-Sectional Studies ; Benzoxazines/therapeutic use ; Heterocyclic Compounds, 3-Ring/adverse effects ; Hyperglycemia ; Lipids ; Cholesterol ; Lipoproteins, HDL/therapeutic use ; Dyslipidemias/chemically induced ; Dyslipidemias/epidemiology ; Anti-HIV Agents/adverse effects
Chemical Substances	efavirenz (JE6H2O27P8) ; dolutegravir (DKO1W9H7M1) ; Blood Glucose ; Benzoxazines ; Heterocyclic Compounds, 3-Ring ; Lipids ; Cholesterol (97C5T2UQ7J) ; Lipoproteins, HDL ; Anti-HIV Agents
Language	English
Publishing date	2023-12-20
Publishing country	England
Document type	Journal Article
ZDB-ID	1004226-x
ISSN	1365-2060 ; 1651-2219 ; 0785-3890 ; 1743-1387
ISSN (online)	1365-2060 ; 1651-2219
ISSN	0785-3890 ; 1743-1387
DOI	10.1080/07853890.2023.2295435
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 680: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

To top

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito